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StabilityAbstract The present work was aimed to separate, identify and characterize the major degradation
products of tramadol hydrochloride and ketorolac tromethamine. A rapid, speciﬁc and accurate
stability indicating reversed phase liquid chromatographic method has been developed for simulta-
neous determination of tramadol hydrochloride and ketorolac tromethamine in bulk and formula-
tion. The drugs were subjected to hydrolysis (acidic, alkaline and neutral), oxidation, photolytic and
thermal stress, as per ICH guidelines. The separation, identiﬁcation and characterization of major
stressed degradation products were performed using high performance liquid chromatography com-
bined with quadrupole electrospray ionization mass spectroscopy (LC/ESI-MS) on a C-18 column.
Tramadol hydrochloride was found to degrade in acidic and oxidative conditions while ketorolac
tromethamine undergoes extensive degradation under oxidative, UV and acid hydrolysis stress.
From the mass spectral data, probable structures were assigned to the degradation products. The
identiﬁed major degradation product for tramadol under acid stress may be 1-(30-methoxy-3,4,5,
6-tetrahydro-[1,10-biphenyl]-2-yl)-N,N-dimethylmethanamine. Ketorolac tromethamine was also
found to convert in to numerous degradation products under oxidative stress.
 2016 Publishing services provided by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.
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Tramadol hydrochloride (TRH) is (1R, 2R)-rel-2-[(dimethyla
mino)-methyl]-1-(3-methoxyphenyl) cyclohexanol.1 It is a l-
opioid receptor agonist and centrally acting analgesic. Ketoro-
lac tromethamine (KTM) is (±)-5-benzoyl-2,3-dihydro-1H-
pyrrolizine-1-carboxylic acid, 2-amino-2-(hydroxymethyl)-1,3-
propanediol2 (Fig. 1). It is an analgesic and non-steroidal
anti-inﬂammatory drug (NSAID). It acts by the inhibition of
both cylooxygenase-1 (COX-1) and cylooxygenase-2 (COX-
2) enzymes responsible for inﬂammation.
The combination formulation containing TRH and KTM
is used as an analgesic for the short-term treatment of moder-
ate to severe pain. It has higher analgesic efﬁcacy than each of
its components. Also, it has a faster onset of action and greater
duration of effect.
KTM has been investigated either alone or in combination
with other drugs by various methods like LC–MS/MS,3
HPTLC,4 LC–MS5 and HPLC.6–8
Devarajan et al. have studied acid and base degradation of
KTM alone using 0.5 N HCl and 0.5 N NaOH respectively
with a reaction time of 10 min. HPTLC was used to separate
one degradation product formed under both conditions.4
Structure of this product was not elucidated. Salaris et al. have
carried out alkali and acid degradation study under similar
reaction conditions as reported by Devarajan et al.5 They have
used LC–MS for the identiﬁcation of degradation products.
No degradation product was reported under the experimental
conditions probably due to very short reaction time.
Various techniques have been reported for the investigation
of TRH which includes UV9 and HPLC.9–15 Only two reports
exist involving the study of compatibility and stability of bin-
ary mixtures of TRH and KTM injection concentrate and
diluted infusion using HPLC.16,17 LC–MS is a sensitive tech-
nique used for the identiﬁcation of other analytes in the pres-
ence of their degradation products.18–21
No study so far has been reported on characterization of
degradation products of this combination under stress condi-
tions prescribed by ICH Q1A(R2).22 It is difﬁcult to investigate
multicomponent formulation along with degradationFigure 1 Structures of (a) TRH, (b) KTM.products. The challenge is to separate the drugs from the num-
ber of degradation products generated. This paper describes
HPLC–UV and HPLC–MS method to determine TRH and
KTM simultaneously in the presence of their degradation
products. Relative stability of both drugs under various stress
conditions has been assessed and identiﬁcation of major degra-
dation products has been performed with the help mass
spectroscopy.
2. Experimental
2.1. Chemicals and reagents
Pure TRH was obtained as a gift sample from Alkem Labora-
tories, Gujarat. KTM was provided as a gift sample by Dr.
Reddy’s Laboratory, Hyderabad. Methanol, acetonitrile and
water were of HPLC grade (Merck, India). Formic acid
(AR) was used for pH adjustment. Analytical reagent grade
hydrochloric acid, sodium hydroxide and hydrogen peroxide
used in the present study were purchased from S.D. Fine
Chemicals (Mumbai, India). Voydol-C capsules manufactured
by RAAM Laboratories were used for analysis. Each capsule
contains 25 mg of TRH and 10 mg of KTM.
2.2. Instrumentation
2.2.1. HPLC–UV specifications
Dionex Ultimate 3000 HPLC (UV detection simultaneous
determination at four wavelengths) with chromeleon software
version 6.8 SR 10 build 2818 equipped with column oven and
autosampler was used. Detection wavelength was set at
270 nm.
2.2.2. HPLC–MS specifications and chromatographic
conditions
Dionex Ultimate 3000 HPLC (UV detection simultaneous
determination at four wavelengths) with chromeleon software
version 6.8 SR 10 build 2818 equipped with column oven,
online degasser and autosampler was used. Applied biosystems
MS (MDS SCIEX, 4000 Q TRAP) equipped with Turbo V
electrospray ionization source (ESI) and analyst version 1.4.2
software were used for data acquisition and processing. The
samples were infused into the mass spectrophotometer from
HPLC system through ESI interface. The optimized parame-
ters are given in Table 1. The samples were separated on a
Neosphere C-18 column (4.6 internal diameter, 250 mm length,
5 lm particle size, Hexon Laboratories Pvt. Ltd.). The mobile
phase composition was water: methanol: acetonitrile (53:23:24,
v/v/v) with 0.5% of formic acid. The mobile phase ﬂow rate
was 1.0 ml/min and the detection wavelength was 270 nm.
Injection volume was 25 ll.
Other equipments used were hot air oven (Dolphin, PPI
unix96), pH meter (HANNA, HI 2211) and analytical balance
(Shimadzu AUX 220, Japan).
2.3. Selection of analytical wavelength
Spectra of TRH (20 lg mL1) and KTM solution
(10 lg mL1) were obtained separately using double beam
UV Visible spectrophotometer (Shimadzu UV-1800).
Table 1 Mass speciﬁcations.
S. no. Parameter TRH KTM
1 Source temperature 600 C 600 C
2 Mass range 50–500 amu 50–500 amu
3 Ionization mode Positive ion
mode
Negative
ion mode
4 Declustering potential +18 V 10 V
5 Entrance potential +10 V 10 V
6 Ion spray voltage 5500 V 5500 V
7 Sheath gas/nebulizing gas
and desolvation gas
Nitrogen at
50 psi
Nitrogen
50 psi
8 Curtain gas velocity Nitrogen,
30 psi
Nitrogen,
30 psi
Figure 2 Overlay of absorption curves of TRH solution (20 lg/ml)
and KTM solution (10 lg/ml).
Figure 3 Chromatogram of TRH and KTM.
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Literature survey revealed the use of phosphate buffer, triethyl
amine and acetonitrile as a mobile phase. Hence, it was
decided to develop a mobile phase compatible with MS with
minimum amount of organic modiﬁers. Numerous mobile
phases in various ratios were tried so as to obtain well resolved
peaks of drugs from the degradation products. The selection of
mobile phase was made on the basis of peak shape and resolu-
tion between drug and degradation products.
The mobile phase consisting of water:methanol:acetonitrile
(53:23:24 v/v/v) with 0.5% formic acid was prepared. It was ﬁl-
tered through a 0.45 l membrane ﬁlter and sonicated for
15 min before use.
3.1. Forced degradation studies
Stress degradation studies were carried out on the bulk drug
singly and in combination. It was also extended for formula-
tion to study the presence of additional degradation products
that may arise from drug excipient interaction. TRH,
31.25 mg and KTM, 12.5 mg were weighed and transferred
to 25 ml of water leading to a concentration of 1250 lg mL1
of TRH and 500 lg mL1 of KTM. An aliquot (5 ml) of this
solution was mixed with 5 ml of stressor (2 N HCL/2 N
NaOH/water/3% H2O2). The solutions were heated at 90 C
for 5 h. Similarly, 5 ml of this solution was exposed to short
wave UV light in UV cabinet. After stress testing, the acid
solution was neutralised using 5 ml of 2 N NaOH. Base solu-
tion was also neutralised using 5 ml of 2 N HCL. The solutions
were further diluted to 50 ml with mobile phase. Solution con-
taining formulation was ﬁltered before dilution.
Solid state photolytic studies were performed by exposing
thin layers of drugs to short wave UV light for 12 h and diluted
as described above. Drugs in the solid state were also exposed
to dry heat at 80 C for 8 h. After these treatments, all
solutions and blanks were ﬁltered from 0.25 lm nylon syringe
ﬁlter for injection into HPLC system. The blank spectra
were subtracted from the analyte spectra during mass
investigation.
3.2. Assay of formulation
A powder equivalent to 31.25 mg of TRH and 12.5 mg of
KTM was weighed accurately and dissolved in 20 ml of mobilephase and sonicated for 15 min and volume was made to 25 ml
with mobile phase resulting in 1250 lg mL1 solution of TRH
and 500 lg mL1 solution of KTM. The solution was ﬁltered
through Whatman ﬁlter paper No. 41. An aliquot (2.5 ml) of
the solution was further diluted to 50 ml resulting in a concen-
tration of 62.5 lg mL1 for TRH and 25 lg mL1 for KTM.
Sample solution prepared individually six times was analyzed
under chromatographic condition described above. The area
under the curve of each peak was measured at 270 nm. The
amount of each drug present in the sample solution was deter-
mined using calibration curves.
3.3. Stability of sample solution
The drug solution containing 62.5 lg mL1 of TRH and
25 lg mL1 of KTM were injected on column at deﬁned inter-
vals for 8 h and peak area was noted.
4. Method validation
Method was validated as per the ICH guidelines.23 The follow-
ing parameters were checked:
4.1. Linearity
TRH, 31.25 mg and KTM, 12.5 mg were weighed and trans-
ferred to a 25 ml volumetric ﬂask containing 15 ml of HPLC
grade water. The solution was sonicated for 5 min and volume
was made up to 25 ml with HPLC grade water. The resulting
stock solution containing 1250 lg mL1 of TRH and
500 lg mL1 of KTM was further diluted with mobile phase
90 V.S. Tambe et al.to get mixed standards in the concentration range of
12.5–125 lg mL1 for TRH and 5–50 lg mL1 for KTM.
The solutions were analyzed for peak area. The whole proce-
dure was repeated thrice from weighing of drugs. The averageFigure 4 LC–MS chromatogramof peak area of three reading was calculated and was plotted
against concentration to obtain calibration curve. The %
RSD of peak area after independent analysis carried out thrice
at each concentration level was considered to establish range.of (a) TRH and (b) KTM.
Table 2 Stability of sample solution.
Duration Peak area
1 h 2 h 4 h 8 h
TRH 38406.9 38705.1 38703.4 38684.3
KTM 37878.1 38713.8 38386.4 38268.4
Figure 5 Blank chromatogram.
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and ﬁsher variance ratio (F) were considered in the determina-
tion of linearity.Figure 6 Residual plot4.2. Recovery
Recovery studies were performed in order to ﬁnd out how
much of the analytes is retrieved during the process of sample
preparation. Brieﬂy, quantity of 37.5 mg, 31.25 mg and 25 mg
of TRH was spiked separately in the capsule blend corre-
sponding to 80%, 100% and 120% of the concentration of
the test solution. These solutions were also spiked with
10 mg, 12.5 mg and 15 mg of KTM. Further, extraction proce-
dure as elaborated in assay section was exercised. The experi-
ment was performed in triplicate. Percent recovery and RSD
(%) were calculated.
4.3. Precision
Method repeatability was established by injecting test and
standard solution corresponding to 62.5 lg mL1 of TRH
and 25 lg mL1 of KTM after independent preparation of
each solution. RSD (%) of peak area was calculated. Similarly,
% RSD of six independent assay performed on different days
was considered. Intermediate precision was carried out by ana-
lyzing samples by different analyst on different instrument
(Cyberlab).
4.4. Limit of detection and limit of quantitation
The detection and quantitation limits were calculated from cal-
ibration curves. The formulae used were LOD= 3.3 r/S and
LOQ= 10 r/S (where r is standard deviation of peak area
of signal obtained after injection of blank and S is the slope
of calibration curve).
4.5. Robustness
Effect of small deliberate changes in detecting wavelength by
±2 nm, column (SMTSAM-C18 column, 4.6  250 mm, parti-for TRH and KTM.
Table 3 Summary of method validation parameters.
S. No. Parameters TRH KTM
1 Linearity (lg mL1) 12.5–125 5–50
Correlation coeﬃcient 0.998 0.999
Experimental variance (r2e) 73422.15 938105.2
Lack-of-ﬁt variance (r2 Lof) 97972.19 2,713,519
Fisher variance ratio (F) experimental 1.33 2.89
Fisher variance ratio (F) tabulated 2.96 2.96
2 % Assay (S.D.) 100.2 (1.2) 99.9 (1.3)
3 Recovery (% RSD) n= 3 At 80% 100.3 (0.2) 99.8 (0.3)
At 100% 100.1 (0.1) 99.9 (0.2)
At 120% 100.3 (0.3) 100.1 (0.3)
4 LOD (lg mL1) 0.48 0.21
5 LOQ (lg mL1) 1.4 0.63
6 Precision Repeatability (n= 6)
Mean % assay (RSD)
100.1 (0.12) 99.9 (0.32)
Intermediate precision (n= 6)
Mean % assay (RSD)
100.2 (0.43) 100.3 (0.41)
7 Robustness (% assay) Change in ﬂow rate (0.9 ml/min) 100.2 99.8
Change in ﬂow rate (1.1 ml/min) 100.3 99.7
Change detection wavelength 268 nm 99.8 99.9
Change detection wavelength 272 nm 98.9 99.2
Change in column 99.5 100.5
Figure 7 Chromatogram of TRH and KTM showing separation
of drugs from their degradation products under acidic stress.
92 V.S. Tambe et al.cle size 5 lm) and ﬂow rate by ±0.1 ml/min on assay was
checked.
5. Results
5.1. Selection of analytical wavelength
The analytical wavelength selected was 270 nm at which both
drugs exhibited substantial absorbance as shown in Fig. 2.
The wavelength was selected by acquiring absorption spectra
of TRH and KTM.
5.2. Optimization of LC–MS conditions
In order to determine the best conditions for the effective sep-
aration, mobile phase containing various ratios of water and
methanol was initially used, wherein extensive tailing for
TRH was observed. Mobile phase consisting of water: acetoni-
trile: methanol (53:24:23 v/v/v) with 0.5% formic acid showedgood resolution, peak shape and desired elution as shown in
Fig. 3.
The ESI source conditions were also optimized to obtain a
good signal and high sensitivity. The conditions like drying gas
ﬂow, nebulizing gas ﬂow, drying gas temperature and, voltage
were optimized to maximize the ionization in the source,
response and sensitivity so as to characterize the degradation
products. LC–MS chromatograms for TRH and KTM are
shown in Fig. 4.
To identify the origin of degradation products, the single
drug under stressed condition was introduced into the column.
TRH and its degradation products were analyzed at positive
ionization mode due to the presence of basic amino group in
TRH. KTM and its degradation products were analyzed at
negative ionization mode due to the rapid conversion of
KTM in to carboxylate ion.
5.3. Stability of sample solution
No signiﬁcant difference was found in the peak areas of stan-
dard solutions of drugs for 8 h (Table 2). This means that the
solutions of TRH and KTM are stable for at least 8 h.
5.4. Method validation
The method was found to be selective as the peaks due to both
drugs were well resolved from each other and from any other
peak due to blank and degradation products. The excipient
blend and diluent blank do not show any peak at the retention
time of the TRH and KTM as shown in Fig. 5.
The method was found to be linear over the concentration
range of 12.5–125 (lg mL1) for TRH and 5–50 (lg mL1) for
KTM. The correlation coefﬁcients were 0.998 and 0.999 for
TRH and KTM respectively. The residuals shown in Fig. 6
do not show any tendency. The calculated experimental value
of ﬁsher variance ratio is compared against the critical value of
Figure 8 Positive ion ESI LC–MS line spectrum of degradation products of TRH at 5.86 min.
Figure 9 Degradation pathway of TRH under acid hydrolysis
(Rt: 5.86 min, m/z: 246.1).
Figure 11 Chromatogram of TRH and KTM after oxidative
stress showing separation of drugs from their degradation
products.
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tabulated value of F is greater the experimental value. This
proves the linearity of the method.
The values of % recovery are presented in Table 3. The
results indicate, good precision and accuracy was observed.
For repeatability study, % RSD of TRH and KTM were
found to be 0.12 and 0.32 respectively. The value of % RSD
of peak area was less than 2%, indicating good precision of
the developed method. The LOD and LOQ of the method is
0.48 and 1.4 lg mL1 respectively for TRH, while they are
0.21 and 0.63 lg mL1 for KTM. These values indicate capa-
bility of the method to determine dilute solutions. Robustness
study was carried out by performing deliberate changes in
detecting wavelength, column and ﬂow rate. This revealed no
signiﬁcant variation in % assay, retention time, tailing factor
and theoretical plates. Other method validation parameters
are summarized in Table 3.Figure 10 Negative ion ESI LC–MS line spectrum5.5. Forced degradation studies
5.5.1. Acid stress studies
The comparison of chromatograms obtained with degraded
samples and pure samples revealed the presence of one major
additional peak in the degraded samples of TRH at retention
time of 5.86 min. KTM also showed degradation products at
retention time of 2.54 min and 7.01 min. The results are pre-
sented in Fig. 7.
TRH and KTM were found to degrade signiﬁcantly under
acidic conditions. The degradation products of TRH and
KTM were separately monitored under positive and negative
ion modes respectively on LC–MS. TRH showed a degrada-
tion product with a mass to charge ratio of 246.2 as shown
in Fig. 8. The probable degradation pathway is shown in
Fig. 9. The loss of mass 18 is attributed to the elimination of
water. KTM also showed two major degradation products atof degradation products of KTM at 7.01 min.
94 V.S. Tambe et al.Rt of 2.54 (m/z of 198.1) and 7.01 (m/z of 343.2) as seen in
Fig. 10.
5.5.2. Oxidative stress studies
The chromatogram of drugs under oxidative stress is shown in
Fig. 11. The ESI LC–MS chromatograms of KTM under neg-
ative ion mode are presented in Fig. 12. TRH has shown
degradation product with m/z value of 280.2 and 195.4.
KTM was found to degrade to products with m/z values of
166.1, 306.1, 348.0, 270.1 and 316.0.
Table 4 summarizes the probable structures of the major
degradation products of both drugs under acidic and oxidative
stress.
6. Discussion
Previous reports have described only physical and chemical
compatibility between the two drugs. Lin et al. have assessed
compatibility and stability of mixtures of KTM and TRHFigure 12 Negative ion ESI LC–MS line spectrum of degradation
7.04 min.injection concentrate and diluted infusion solution by
HPLC–UV method. They have reported that the mixture is
stable for at least seven days at ambient conditions. Stefano
et al. have assessed stability TRH injection admixed with
selected pain drugs.
The HPLC method carried out in this study was an attempt
at developing a simple chromatographic system capable of
eluting and resolving TRH and KTM from their degradation
products. Preliminary investigations were directed toward car-
rying out stress studies and developing HPLC method that can
resolve all degradation products from drug peak. Parameters
assessed were in the nature of mobile phase, its composition
and pH. The results show that water: acetonitrile: methanol
(53:24:23 v/v/v) with 0.5% formic acid was a suitable mobile
phase for the determination of both drugs because of its excel-
lent resolution and appropriate retention time.
TRH and KTM are soluble in water. TRH is soluble in
acidic conditions and forms globules under basic conditions.
KTM is insoluble at acidic pH. It is soluble under basic and
neutral conditions. KTM gives crystalline product after neu-products of KTM at (a) 1.98 min (b) 3.76 min (c) 4.29 min (d)
Table 4 Summary of degradation products of TRH and KTM along with the probable structures of some compounds.
Retention
time (min)
Origin of peak Best possible
molecular
formula
Theoretical
mass
Experimental
mass
Probable structure
3.02 TRH cation C16H26NO2
+ 265.2
265.2 (M
+ 1)+
16.53 KTM Anion C15H12NO3
 254.1
254.1
(M  1)+
5.86
TRH Major DP
(Acid hydrolysis)
C16H24NO
+ 247.2 247.2
4.29
KTM DP (Acid
Hydrolysis)
C13H12NO
 198.1 198.1
7.01
KTM DP (Acid
Hydrolysis)
C22H19N2O2
 343.2 343.2
2.43
TRH major DP
(oxidation)
C15H22NO4
+ 280.2 280.2
1.98
KTM DP
(oxidation)
C8H8NO3
 166.1 166.1
3.76
KTM DP
(oxidation)
C15H16NO6
 306.1 306.1
(continued on next page)
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Table 4 (continued)
Retention
time (min)
Origin of peak Best possible
molecular
formula
Theoretical
mass
Experimental
mass
Probable structure
4.29
KTM DP
(oxidation)
C15H10NO9
 348.0 348.0
6.10
KTM DP
(oxidation)
C15H12NO4
 270.1 270.1
7.04
KTM DP
(oxidation)
C15H10NO7
 316.0 316.0
96 V.S. Tambe et al.tralization. After stress testing, TRH displayed slight precipita-
tion in basic medium which might be due to precipitation of
tramadol from its hydrochloride salt under basic conditions.
Rest all solutions were clear. All solution dispersed uniformly
when diluted with mobile phase to give clear solutions.
This method has demonstrated good precision and recov-
ery. The results were not majorly affected after making delib-
erate changes in method parameters.
In this study, we have also attempted the characterization
of major degradation products of TRH and KTM. During
LC–MS study TRH was ionized under positive mode due to
the protonation of amino group while KTM was studied under
negative ion mode owing to carboxylate ion formation. TRH
was found to degrade under acidic conditions with the elimina-
tion of water, while KTM has shown higher mass degradation
product which may be due to the presence of pyrrole ring
which tends to polymerize under acidic conditions. Both drugs
were found to degrade signiﬁcantly under oxidative stress as
compared to all stress conditions. KTM has a high oxidation
potential as compared to TRH.
Results of degradation studies at different conditions
revealed that TRH undergoes extensive degradation at oxida-
tive stress as compared to acid or basic hydrolysis stress. It was
found to be stable at neutral stress and to UV light. KTM was
also found to degrade more under oxidative stress as compared
to its degradation under exposure to UV light followed by
acidic stress. After exposure to UV light, it was found toundergo degradation without the appearance of additional
peaks. This conﬁrms the generation of nonchromophoric
degradation products. It was found to have good stability
toward dry heat. No additional peak was displayed in stressed
samples of formulation.
This paper thus has focused on stability of both drugs sin-
gly and in combination.
7. Conclusion
Quality plays a pivotal role in the determination of safety and
efﬁcacy of any pharmaceutical formulation. The presence of
potential degradants may alter the properties of formulation.
The developed HPLC method is a stability indicating and
has been validated for accuracy, precision, robustness and
speciﬁcity. This method is useful for simultaneous determina-
tion of TRH and KTM. Both drugs were found to degrade
under oxidative conditions. The structures of major degrada-
tion products under acid and oxidative stress have been pro-
posed. The proposed method can also be used for the
quantitation of tramadol hydrochloride and ketorolac tro-
methamine separately in the presence of their degradation
products.
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